2 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Impulsive Behavior: new trials by email Literature Review of Impulsive Behavior trials Research Report on Impulsive Behavior
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Oral Naltrexone In Pediatric Eating Disorders Naltrexone Hydrochloride, Control - Anorexia Nervosa/Bulimia, Anorexia in Adolescence | Phase 2 / Phase 3 | Terminated | Rosemary Claire Roden | 9 | 2022-04-22 | 2025-08-19 |
| Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks Topiramate, Placebo Comparator - Prader-Willi Syndrome | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 69 | 2012-12-01 | 2018-04-11 |
Feeding and Eating Disorders (2) · Anorexia Nervosa (1) · Bulimia (1) · Bulimia Nervosa (1) · Prader-Willi Syndrome (1)
Behavior (2) · Mental Disorders (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Signs and Symptoms, Digestive (2) · Abnormalities, Multiple (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hyperphagia (1) · Imprinting Disorders (1) · Intellectual Disability (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1)
Naltrexone (1) · Topiramate (1)
Assistance Publique - Hôpitaux de Paris (1) · Rosemary Claire Roden (1)
France (1) · United States (1)